Oral bacitracin: A consideration for suppression of intestinal vancomycin-resistant enterococci (VRE) and for VRE bacteremia from an apparent gastrointestinal tract source

dc.creatorTran, Truc T.
dc.creatorPalmer, Hannah R.
dc.creatorWeimar, Marion R.
dc.creatorArias, Cesar A.
dc.creatorCook, Gregory M.
dc.creatorMurray, Barbara E.
dc.date.accessioned2020-07-30T20:32:46Z
dc.date.accessioned2023-06-05T14:31:59Z
dc.date.available2020-07-30T20:32:46Z
dc.date.available2023-06-05T14:31:59Z
dc.date.created2020-07-30T20:32:46Z
dc.date.issued2015
dc.identifier1537-6591
dc.identifierhttp://hdl.handle.net/20.500.12495/3626
dc.identifierhttps://doi.org/10.1093/cid/civ130
dc.identifierinstname:Universidad El Bosque
dc.identifierreponame:Repositorio Institucional Universidad El Bosque
dc.identifierhttps://repositorio.unbosque.edu.co
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6638938
dc.languageeng
dc.publisherOxford University Press
dc.publisherClinical Infectious Diseases
dc.relationClinical Infectious Diseases, 1537-6591, Vol 60, Num 11, 2015, pag 1726–1728
dc.relationhttps://academic.oup.com/cid/article/60/11/1726/356045
dc.rightsAcceso abierto
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAcceso abierto
dc.rights2015-06-01
dc.titleOral bacitracin: A consideration for suppression of intestinal vancomycin-resistant enterococci (VRE) and for VRE bacteremia from an apparent gastrointestinal tract source


Este ítem pertenece a la siguiente institución